Analysis of methylation and expression profile of MOB1A in blood, saliva, and tissue of patients with oral squamous cell carcinoma (OSCC) and precancerous patients

Document Type : Original Article

Authors

1 MSc of Molecular Genetics, Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran

2 Associate professor, Department of Periodontology, University of Medical Sciences, Zahedan, Iran

3 Professor, Department of Biology, University of Sistan and Baluchestan, Zahedan, Iran

Abstract

Background: Oral squamous cell carcinoma (OSCC) is considered the most common type of oral cavity malignancy worldwide. OSCC accounts for more than 90% of all oral neoplasms. This cancer affects the lips, palate, and tongue and the average survival rate of patients is 5 years. The most important risk factors of OSCC are alcohol and tobacco and mostly middle-aged males are affected. The hippo signaling pathway is a tumor suppressor pathway that regulates tissue growth via balancing cell proliferation, death, and differentiation. MOB1A is a component of the hippo pathway that binds to Lats1/2 and may function as a tumor suppressor in human cancer cells. So, deregulation of the hippo pathway is the most common feature of solid tumors. Methods: In this research, 10 different cases of MOB1A promoter methylation status were compared with each other regarding 20 healthy controls (blood and saliva samples), 20 high-risk patients (blood and saliva samples), and OSCC patients (20 tissue, 12 blood, and saliva samples). Furthermore, the expression profile of MOB1A was investigated in the saliva cDNA of 12 healthy controls, and 12 high-risk patients as well as saliva and tissue cDNA of 12 patients with OSCC by Real-time PCR technique. Results: Our results showed that, among all of the investigated conditions, the only status that confirmed a significant difference was a comparison of MOB1A methylation status in high-risk group blood and OSCC group tissue (p-value: 0.025). Moreover, there was no significant difference in the expression profile of MOB1A in any of the studied conditions between the three groups. Conclusion: From the significant difference observed in the methylation status of MOB1A in precancerous patients' blood and OSCC tissue, we may be able to conclude that the methylation status of the gene can be different in various samples. Moreover, it may be extracted from our findings that expression levels of MOB1A in the three aforementioned groups are not affected by various types of samples.

Keywords

Main Subjects

References

Chen, X.,Zhang, F., et al. (2015). The clinical significance of CDK1 expression in oral squamous cell carcinoma. Med Oral Patol Oral Cir Bucal.20, e7-12.
Choi, S., Myers, JN.(2008).Molecular pathogenesis of oral squamous cell carcinoma: implications for therapy. J Dent Res.87,14-32.
Yardimci, G.,Kutlubay,Z.,Engin,B.(2014). Precancerous lesions of the oral mucosa. World J Clin   Cases.  2, 866-872.
Shirani, S.,Kargahi,N.,Razavi,SM.(2014). Epithelial dysplasia in the oral cavity. Iran J Med Sci. 39, 406-417.
Messadi, D.V.(2013). Diagnostic aids for the detection of oral precancerous conditions. Int J Oral Sci. 5, 59-65.
Tatullo, M.,Marelli,M.,Amantea,M., et al.(2015). Bioimpedance Detection of Oral Lichen Planus Used as Preneoplastic Model. J Cancer. 6, 976-983.
Abylkassov, R. and  Xie,Y.(2016). Role of Yes-associated protein in cancer: An update. Oncol Lett. 12, 2277-2282.
Kim, CL., Choi, SH., MO, JS,.(2019). Role of the Hippo pathway in fibrosis and cancer. Cells, 8, 1-22.
Chow, A., Hao, Y. and Yang, X.(2010). Molecular characterization of human homologs of yeast MOB1. Int J Cancer. 126, 2079-2089.
Barron, D.A. and Kagey, J.D.(2014). The role of the Hippo pathway in human disease and tumorigenesis. Clin Transl Med. 3, 25.
Speel, E.J.(2017). HPV Integration in Head and Neck Squamous Cell Carcinomas: Cause and Consequence. Recent Results Cancer Res. 206, 57-72.
Rigi Ladiz,M.A.,Najafi,M.,Kordi Tamandani,D.M.(2016).Contribution of LATS1 and LATS2 promoter methylation in OSCC development. J. Cell Commun. Signal.11,49-55.
Peres-Sayans,M.,Somoza-Martin,J.M.,et al.(2009).Genetic and molecular alterations associated with oral squamous cell cancer.Oncol Rep.22,1277.
Pinosa,F.,Begheldo,M.,Pasternak,T.,et al.(2013).The Arabidopsis Thaliana Mob1a gene is required for organ growth and correct tissue patterning of the root tip. Annals of Botany.112,1803-1814.
Eisazaei,S., Nakhaee-Moghadam,M.,Kordi Tamandani,D.M.(2022). Analysis of expression profiles GLI3A, LATS2, and MOB1A genes in patients with congenital hypothyroidism.J.EP.3,21-26.
Duhart, J.C and Raftery, L.A.(2020). MOB family proteins: Regulatory partners in Hippo and Hippo-like intracellular signaling pathways. Cell Dev.Biol. 161,1-22.
Kosaka, Y., et al.(2007). Clinical significance of the loss of MATS1 mRNA expression in colorectal cancer. Int J Oncol. 31, 333-338.
Zhou, D., Conrad, C. et al.(2009). Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through the inactivation of the Yap1 oncogene. Cancer Cell. 16, 425-438.
Shen,J.,Su,J.,Wu,D., et.al.(2015). Growth Inhibition Accompanied by MOB1 Upregulation in Human Acute LymphoidLeukemia Cells by 3-Deazaneplanocin A.Biochemical Genetics.53,268-279.
Zhang, R., Zhang, H., Zhu, W., Pardee, A.B., Co, R.J., and Liang, P.(1997).Mob-1, a Ras target gene, is overexpressed in colorectal cancer.Oncogene.14.13,1607-1610.
Journal of Epigenetics
Volume 3, Issue 2 - Serial Number 2
September 2022
Pages 39-44

Files

History

  • Receive Date: 09 September 2022
  • Revise Date: 10 May 2023
  • Accept Date: 13 May 2023

Share

How to cite

Statistics